Literature DB >> 26112421

Presenilin-1 familial Alzheimer's disease mutation alters hippocampal neurogenesis and memory function in CCL2 null mice.

Tomomi Kiyota1, Christine M Morrison2, Guihua Tu2, Bhagyalaxmi Dyavarshetty2, Robert A Weir2, Gang Zhang2, Huangui Xiong2, Howard E Gendelman2.   

Abstract

Aberrations in hippocampal neurogenesis are associated with learning and memory, synaptic plasticity and neurodegeneration in Alzheimer's disease (AD). However, the linkage between them, β-amyloidosis and neuroinflammation is not well understood. To this end, we generated a mouse overexpressing familial AD (FAD) mutant human presenilin-1 (PS1) crossed with a knockout (KO) of the CC-chemokine ligand 2 (CCL2) gene. The PS1/CCL2KO mice developed robust age-dependent deficits in hippocampal neurogenesis associated with impairments in learning and memory, synaptic plasticity and long-term potentiation. Neurogliogenesis gene profiling supported β-amyloid independent pathways for FAD-associated deficits in hippocampal neurogenesis. We conclude that these PS1/CCL2KO mice are suitable for studies linking host genetics, immunity and hippocampal function.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemokine; Hippocampus; Long-term potentiation; Morris water maze; Neurogliogenesis

Mesh:

Substances:

Year:  2015        PMID: 26112421      PMCID: PMC4567522          DOI: 10.1016/j.bbi.2015.06.014

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  43 in total

Review 1.  Milestones of neuronal development in the adult hippocampus.

Authors:  Gerd Kempermann; Sebastian Jessberger; Barbara Steiner; Golo Kronenberg
Journal:  Trends Neurosci       Date:  2004-08       Impact factor: 13.837

Review 2.  LTP and LTD: an embarrassment of riches.

Authors:  Robert C Malenka; Mark F Bear
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

3.  Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.

Authors:  K Duff; C Eckman; C Zehr; X Yu; C M Prada; J Perez-tur; M Hutton; L Buee; Y Harigaya; D Yager; D Morgan; M N Gordon; L Holcomb; L Refolo; B Zenk; J Hardy; S Younkin
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

4.  The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice.

Authors:  Paul H Wen; Patrick R Hof; Xiaoping Chen; Karen Gluck; Gregory Austin; Steven G Younkin; Linda H Younkin; Rita DeGasperi; Miguel A Gama Sosa; Nikolaos K Robakis; Vahram Haroutunian; Gregory A Elder
Journal:  Exp Neurol       Date:  2004-08       Impact factor: 5.330

Review 5.  Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration.

Authors:  Edward H Koo; Raphael Kopan
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

6.  Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits.

Authors:  Jorge J Palop; Brian Jones; Lisa Kekonius; Jeannie Chin; Gui-Qiu Yu; Jacob Raber; Eliezer Masliah; Lennart Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-24       Impact factor: 11.205

7.  Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease.

Authors:  Yong-Xin Sun; L Minthon; A Wallmark; S Warkentin; K Blennow; S Janciauskiene
Journal:  Dement Geriatr Cogn Disord       Date:  2003       Impact factor: 2.959

8.  Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis.

Authors:  Eric R Anderson; Howard E Gendelman; Huangui Xiong
Journal:  J Neurosci       Date:  2004-08-11       Impact factor: 6.167

9.  Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression.

Authors:  S Molinari; R Battini; S Ferrari; L Pozzi; A S Killcross; T W Robbins; A Jouvenceau; J M Billard; P Dutar; Y Lamour; W A Baker; H Cox; P C Emson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

10.  CD36 mediates the innate host response to beta-amyloid.

Authors:  Joseph B El Khoury; Kathryn J Moore; Terry K Means; Josephine Leung; Kinya Terada; Michelle Toft; Mason W Freeman; Andrew D Luster
Journal:  J Exp Med       Date:  2003-06-09       Impact factor: 14.307

View more
  11 in total

1.  Reboxetine Treatment Reduces Neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer's Disease: Role of CCL2.

Authors:  Irene L Gutiérrez; Marta González-Prieto; Javier R Caso; Borja García-Bueno; Juan C Leza; José L M Madrigal
Journal:  Mol Neurobiol       Date:  2019-07-11       Impact factor: 5.590

2.  Dynamic expression of the mouse orthologue of the human amyotropic lateral sclerosis associated gene C9orf72 during central nervous system development and neuronal differentiation.

Authors:  Ross Ferguson; Eleni Serafeimidou-Pouliou; Vasanta Subramanian
Journal:  J Anat       Date:  2016-08-01       Impact factor: 2.610

3.  Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice.

Authors:  Tomomi Kiyota; Jatin Machhi; Yaman Lu; Bhagyalaxmi Dyavarshetty; Maryam Nemati; Izumi Yokoyama; R L Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2018-03-17       Impact factor: 3.478

4.  Induction of a Na+/K+-ATPase-dependent form of autophagy triggers preferential cell death of human immunodeficiency virus type-1-infected macrophages.

Authors:  Gang Zhang; Brian T Luk; Morcel Hamidy; Liangfang Zhang; Stephen A Spector
Journal:  Autophagy       Date:  2018-07-23       Impact factor: 16.016

5.  CD4+ effector T cells accelerate Alzheimer's disease in mice.

Authors:  Jatin Machhi; Pravin Yeapuri; Yaman Lu; Emma Foster; Rupesh Chikhale; Jonathan Herskovitz; Krista L Namminga; Katherine E Olson; Mai Mohamed Abdelmoaty; Ju Gao; Rolen M Quadros; Tomomi Kiyota; Liang Jingjing; Bhavesh D Kevadiya; Xinglong Wang; Yutong Liu; Larisa Y Poluektova; Channabasavaiah B Gurumurthy; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroinflammation       Date:  2021-11-19       Impact factor: 8.322

6.  Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer's Disease.

Authors:  Christine M Embury; Bhagyalaxmi Dyavarshetty; Yaman Lu; Jayme L Wiederin; Pawel Ciborowski; Howard E Gendelman; Tomomi Kiyota
Journal:  J Neuroimmune Pharmacol       Date:  2016-12-13       Impact factor: 4.147

7.  Magnesium Elevation Promotes Neuronal Differentiation While Suppressing Glial Differentiation of Primary Cultured Adult Mouse Neural Progenitor Cells through ERK/CREB Activation.

Authors:  Wang Liao; Mujun Jiang; Mei Li; Congli Jin; Songhua Xiao; Shengnuo Fan; Wenli Fang; Yuqiu Zheng; Jun Liu
Journal:  Front Neurosci       Date:  2017-02-23       Impact factor: 4.677

Review 8.  Anti-retroviral drugs: current state and development in the next decade.

Authors:  Xingquan Zhang
Journal:  Acta Pharm Sin B       Date:  2018-03-07       Impact factor: 11.413

9.  URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer's disease.

Authors:  Tomomi Kiyota; Jatin Machhi; Yaman Lu; Bhagyalaxmi Dyavarshetty; Maryam Nemati; Gang Zhang; R Lee Mosley; Harris A Gelbard; Howard E Gendelman
Journal:  J Neuroinflammation       Date:  2018-05-05       Impact factor: 8.322

10.  Alzheimer's Disease and Its Potential Alternative Therapeutics.

Authors:  Brent Kisby; Juliet T Jarrell; M Enes Agar; David S Cohen; Eric R Rosin; Catherine M Cahill; Jack T Rogers; Xudong Huang
Journal:  J Alzheimers Dis Parkinsonism       Date:  2019-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.